Prime Medicine slides after pricing $125.4M stock offering
Source: SeekingAlpha
2025-07-30 23:51:21 ET
More on Prime Medicine
- Prime Medicine: Pressing Forward With Lead Liver Targeting Indications
- Prime Medicine soars as Jones sees it as an acquisition target
- RFK Jr. looks to fast track rare disease drug approvals (updated)
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
Read the full article on Seeking Alpha
For further details see:
Prime Medicine slides after pricing $125.4M stock offering
First Trust Heitman Global Prime Real Estate ETF
NASDAQ: PRME
PRME Trading
-9.42% G/L:
$3.80 Last:
1,104,129 Volume:
$4.05 Open:
PRME Latest News
March 03, 2026 08:00:00 am
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
PRME Stock Data
$629,079,643
97,403,551
13.07%
59
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
